Thanks Hottod - Jon mentioned in the investor call that Acadia have rights to all indications in North America for Trofenitide, but I thought the only non compete indications for NNZ2591 were Rett and Fragike X is that what you understand?
Ann: Investor Presentation, 14 March 2023, page-41
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.64 |
Change
0.120(0.58%) |
Mkt cap ! $2.641B | |||
| Open | High | Low | Value | Volume |
| $20.60 | $20.77 | $20.53 | $1.271M | 61.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 354 | $20.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.65 | 86 | 3 |
View Market Depth
| Last trade - 11.49am 15/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |